PTC Therapeutics to Participate at Upcoming Investor Conferences

Rhea-AI Summary

PTC Therapeutics, Inc. (NASDAQ: PTCT) announced its participation in two upcoming investor conferences. Management will present at the Cowen Virtual 42nd Annual Health Care Conference on March 7, 2022, at 1:30 p.m. ET, and at the Barclays Global Healthcare Conference on March 17, 2022, at 8 a.m. ET. Both presentations will be available via live webcast on the company’s website, where they will also be archived for 30 days post-event. PTC is committed to developing innovative medicines for rare disorders.

SOUTH PLAINFIELD, N.J., Feb. 23, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the following conferences:

Cowen Virtual 42nd Annual Health Care Conference
Monday, March 7 at 1:30 p.m. ET

Barclays Global Healthcare Conference
Thursday, March 17 at 8 a.m. ET 

The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.

About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Instagram, Facebook, Twitter, and LinkedIn.

For More Information:

Investors:
Kylie O'Keefe
+1 (908) 300-0691
kokeefe@ptcbio.com 

Media: 
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conferences-301486797.html

SOURCE PTC Therapeutics, Inc.

FAQ

What conferences is PTC Therapeutics participating in March 2022?

PTC Therapeutics will participate in the Cowen Virtual 42nd Annual Health Care Conference on March 7, 2022, and the Barclays Global Healthcare Conference on March 17, 2022.

What is the schedule for PTC Therapeutics' presentations in March 2022?

PTC Therapeutics' presentation at the Cowen Virtual Conference is scheduled for March 7, 2022, at 1:30 p.m. ET, and at the Barclays Conference on March 17, 2022, at 8 a.m. ET.

How can I watch PTC Therapeutics' presentations?

The presentations from PTC Therapeutics will be webcast live on their website and archived for 30 days following the events.

What is the ticker symbol for PTC Therapeutics?

The ticker symbol for PTC Therapeutics is PTCT.

What type of company is PTC Therapeutics?

PTC Therapeutics is a biopharmaceutical company focused on developing and commercializing innovative medicines for patients with rare disorders.